About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT00034294

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Approximately 300 patients will be entered into this study taking place throughout the United States, Canada and the United Kingdom. This study aims to determine if an investigational drug is safe and...

Lead sponsor: Genzyme, a Sanofi Company•58 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Genzyme, a Sanofi Company

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Be at least 18 years old.
•Have active mild to moderate C. difficile- Associated Diarrhea (CDAD).
•Be able to tolerate oral medication.
•Not be pregnant or breast-feeding.
•Sign and date an informed consent form.

Related studies

Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

NCT06839209 · Clostridium; Difficile, As Cause of Disease Classified Elsewhere, Clostridium Difficile Diarrhea

TERMINATEDPhase 1

A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea

NCT03793686 · Clostridium Difficile Diarrhea

COMPLETEDPhase 3

Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

NCT00182429 · Clostridium Enterocolitis, Antibiotic-Associated Diarrhea, and more

TERMINATEDPhase 4

Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients

NCT02200328 · Clostridium Difficile Diarrhea

TERMINATEDPhase 4

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

NCT00177970 · Clostridium Difficile-associated Diarrhea (CDAD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment300

Start dateFeb 2002

Last updatedMar 5, 2015

Condition

Clostridium Difficile-Associated Diarrhea Clostridium Enterocolitis Clostridium Difficile Diarrhea Antibiotic-associated Colitis Antibiotic-associated Diarrhea

Locations shown

Mobile, Alabama

Phoenix, Arizona

Tucson, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2015Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions